IMC Chicago’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.7M | Sell |
144,200
-80,600
| -36% | -$28.7M | 0.02% | 495 |
|
|
2025
Q4 | $73.6M | Buy |
224,800
+100
| +0% | +$31.7K | 0.03% | 374 |
|
|
2025
Q3 | $63.4M | Buy |
224,700
+39,500
| +21% | +$11.5M | 0.02% | 395 |
|
|
2025
Q2 | $51.7M | Buy |
185,200
+2,500
| +1% | +$708K | 0.02% | 369 |
|
|
2025
Q1 | $56.9M | Sell |
182,700
-35,900
| -16% | -$10.6M | 0.03% | 290 |
|
|
2024
Q4 | $57M | Sell |
218,600
-600
| -0.3% | -$178K | 0.03% | 309 |
|
|
2024
Q3 | $70.6M | Buy |
219,200
+28,100
| +15% | +$9.19M | 0.04% | 230 |
|
|
2024
Q2 | $59.7M | Buy |
191,100
+62,100
| +48% | +$18.2M | 0.04% | 258 |
|
|
2024
Q1 | $36.7M | Buy |
129,000
+7,600
| +6% | +$2.22M | 0.02% | 313 |
|
|
2023
Q4 | $35M | Buy |
121,400
+4,400
| +4% | +$1.2M | 0.02% | 333 |
|
|
2023
Q3 | $31.4M | Buy |
117,000
+14,200
| +14% | +$3.54M | 0.03% | 285 |
|
|
2023
Q2 | $22.8M | Buy |
102,800
+25,200
| +32% | +$5.85M | 0.02% | 347 |
|
|
2023
Q1 | $18.8M | Sell |
77,600
-14,200
| -15% | -$3.49M | 0.02% | 350 |
|
|
2022
Q4 | $24.1M | Buy |
91,800
+6,800
| +8% | +$1.82M | 0.04% | 274 |
|
|
2022
Q3 | $19.2M | Buy |
85,000
+13,700
| +19% | +$3.32M | 0.02% | 295 |
|
|
2022
Q2 | $17.3M | Buy |
71,300
+5,900
| +9% | +$1.45M | 0.02% | 316 |
|
|
2022
Q1 | $15.8M | Buy |
65,400
+25,200
| +63% | +$5.79M | 0.02% | 379 |
|
|
2021
Q4 | $9.04M | Sell |
40,200
-47,400
| -54% | -$10M | 0.01% | 501 |
|
|
2021
Q3 | $18.6M | Buy |
87,600
+56,200
| +179% | +$12.9M | 0.02% | 374 |
|
|
2021
Q2 | $7.65M | Sell |
31,400
-17,300
| -36% | -$4.26M | 0.01% | 506 |
|
|
2021
Q1 | $12.1M | Sell |
48,700
-18,600
| -28% | -$4.44M | 0.02% | 399 |
|
|
2020
Q4 | $15.5M | Buy |
67,300
+13,000
| +24% | +$3M | 0.02% | 320 |
|
|
2020
Q3 | $13.8M | Buy |
54,300
+24,400
| +82% | +$6.04M | 0.02% | 271 |
|
|
2020
Q2 | $7.05M | Sell |
29,900
-19,000
| -39% | -$4.33M | 0.01% | 318 |
|
|
2020
Q1 | $9.91M | Sell |
48,900
-13,400
| -22% | -$2.93M | 0.02% | 214 |
|
|
2019
Q4 | $15M | Buy |
62,300
+15,600
| +33% | +$3.44M | 0.04% | 167 |
|
|
2019
Q3 | $9.04M | Sell |
46,700
-20,200
| -30% | -$3.88M | 0.03% | 192 |
|
|
2019
Q2 | $12.3M | Buy |
66,900
+24,200
| +57% | +$4.33M | 0.04% | 145 |
|
|
2019
Q1 | $8.11M | Buy |
42,700
+7,000
| +20% | +$1.34M | 0.03% | 170 |
|
|
2018
Q4 | $6.95M | Buy |
+35,700
| New | +$6.96M | 0.02% | 152 |
|
Other funds holding AMGN
VCM
VPM
IMC Chicago's AMGN Position: Q4 2024 in Review
IMC Chicago sold out of Amgen (AMGN) in Q4 2024, closing a stake of 11,946 shares — an estimated $3.54M sold.
IMC Chicago first reported a position in AMGN in Q3 2024 and held it in 1 quarter. The position peaked at $3.85M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- IMC Chicago reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- IMC Chicago sold 11,946 Amgen shares in Q4 2024, an estimated $3.54M.
- IMC Chicago first reported a position in Amgen in Q3 2024 and held it in 1 quarter.
- IMC Chicago's Amgen position peaked at $3.85M in Q3 2024.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.